Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether administration of 150 mg clopidogrel is
effective in reducing the one-year incidence of thromboischemic events in patients with high
on-clopidogrel platelet reactivity compared to 75 mg clopidogrel after elective percutaneous
coronary intervention.